2020
Journal of internal medicine, (2020).288 6 10.1111/joim.13197.
2020
HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2020).17 5 10.1080/21645515.2020.1827882.
2020
FRONTIERS IN IMMUNOLOGY, (2020).11, 10.3389/fimmu.2020.585768.
Estimating the value-based price of new tuberculosis vaccines in India and China.
2020
(2020).
Do evaluations of Tuberculosis Active Case Finding report estimates of resource need? A review of the evidence.
2020
(2020).
2020
BMJ global health, (2020).5 10 10.1136/bmjgh-2020-003006.
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on rifampicin resistant and multidrug resistant tuberculosis in India and China.
2020
(2020).
2020
NATURE MEDICINE, (2020).27, 10.1038/s41591-020-1124-9.
2020
GLOBAL HEALTH ACTION, (2020).13 1 10.1080/16549716.2020.1829829.
